Effects of Manidipine Plus Rosuvastatin Versus Olmesartan Plus Rosuvastatin on Markers of Insulin Resistance in Patients With Impaired Fasting Glucose, Hypertension, and Mixed Dyslipidemia

Conclusion:
Manidipine seems to ameliorate the possible statin-associated increase in insulin resistance as compared with olmesartan in patients with IFG, hypertension, and mixed dyslipidemia.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - February 4, 2013 Category: Cardiology Authors: Liberopoulos, E. N., Moutzouri, E., Rizos, C. V., Barkas, F., Liamis, G., Elisaf, M. S. Tags: Clinical Studies Source Type: research